查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1177595

臨床試驗的全球市場調查報告-產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測

Global Clinical Trials Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日期: | 出版商: Value Market Research | 英文 266 Pages | 商品交期: 最快1-2個工作天內

價格

Value Market Research深入調查臨床試驗的全球市場，並預測未來幾年行業將出現顯著增長。本研究報告提供全球臨床試驗市場相關之完全產業分析，提供市場規模、市場佔有率、增長趨勢、2023年至2028年的預測等。該報告以詳細的市場介紹和突出報告關鍵增長數據的執行摘要為首。接續的章節討論市場價值鏈、波特五力模型和市場吸引力分析。同時還設立關於COVID-19影響分析的獨立章節，以了解市場如何應對疫情。

本報告的市場動態部分詳細介紹了當前的市場推動因素/阻礙、課題/風險和未來機遇。本節對企業戰略家和新產品開發部門非常有用。臨床試驗全球市場調查將市場細分化，並根據收益和/或銷售額的視點提供市場規模。該數據地區細分，同時國家/地區細分。數據是通過深入的初級訪談和世界各地的行業專家收集而來。詳細的調查方法可以在樣本報告中找到。這些市場預測受到最新的社會、政治和經濟變化以及影響該臨床試驗市場的當前市場動態所影響。

臨床試驗市場報告的子章節提供市場競爭力調查，提供一些領先的市場參與者/製造商簡介。這些章節涵括可深入了解競爭對手的產品線、財務狀況、最新發展以及在行業中擁有最高市場佔有率公司所需的豐富資訊。

目錄

第1章 序文

  • 本報告的內容
    • 目的
    • 主要讀者
    • 獨特的銷售主張(USP)及提供服務
  • 調查範圍
  • 調查手法
    • 市場調查流程
    • 市場調查手法

第2章 摘要整理

  • 臨床試驗市場概況
  • 全球臨床試驗市場概述

第3章 臨床試驗- 產業分析

  • 簡介
  • 臨床試驗市場推動市場要素
  • 臨床試驗市場阻礙市場要素
  • 臨床試驗市場機會
  • 臨床試驗市場趨勢
  • 臨床試驗市場波特的五力分析
  • 臨床試驗市場魅力度分析
    • 不同階段市場魅力分析
    • 實驗各種設計市場魅力分析
    • 市場魅力分析:各適應症
    • 市場魅力分析:各地區

第4章 價值鏈分析

  • 臨床試驗的價值鏈分析
  • 臨床試驗的原料分析
    • 原料的清單
    • 臨床試驗原料的製造原清單
    • 臨床試驗的主要原料價格趨勢
  • 潛在的買主清單
  • 行銷流通管道
    • 直銷
    • 間接行銷
    • 行銷流通管道開拓趨勢

第5章 臨床試驗的全球市場分析:不同階段

  • 不同階段概要
  • 全球臨床試驗市場不同階段分析
  • 階段I的市場分析:各地區
  • 階段II的市場分析:各地區
  • 階段III的市場分析:各地區
  • 階段IV的市場分析:各地區

第6章 全球臨床試驗市場分析:實驗各種設計

  • 實驗各種設計概要
  • 全球臨床試驗市場分析:實驗各種設計
  • 介入的市場分析:各地區
  • 研究的市場分析:各地區
  • 擴大存取(點閱)的市場分析:各地區

第7章 全球臨床試驗市場分析:各適應症

  • 各適應症概要
  • 全球臨床試驗市場分析:各適應症
  • 自體免疫/發炎的市場分析:各地區
  • 疼痛管理的市場分析:各地區
  • 腫瘤的市場分析:各地區
  • 中樞神經系統疾病的市場分析:各地區
  • 糖尿病的市場分析:各地區
  • 肥胖的市場分析:各地區
  • 循環系統的市場分析:各地區

第8章 臨床試驗的全球市場分析:各地區

  • 各地區展望
  • 簡介
  • 北美
    • 概要
    • 北美的臨床試驗市場估計:各國
    • 美國
    • 其他北美地區
  • 歐洲
    • 概要
    • 歐洲的臨床試驗市場預測:市場部門別
    • 歐洲臨床試驗市場預測:各國
    • 英國
    • 法國
    • 德國
    • 其他的歐洲地區
  • 亞太地區
    • 概要
    • 亞太地區的臨床試驗市場預測:市場部門別
    • 亞太地區的臨床試驗市場預測:各國
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 南美
    • 概要
    • 南美的臨床試驗市場預測:市場部門別
    • 南美的臨床試驗市場預測:各國
    • 巴西
    • 其他的南美地區
  • 中東&非洲
    • 概要
    • 中東·非洲的臨床試驗市場預測:市場部門別
    • 中東·非洲的臨床試驗市場預測:各國
    • 中東地區
    • 非洲

第9章 臨床試驗企業的競爭情形

  • 臨床試驗市場競爭
  • 夥伴關係/合作/協定
  • 合併·收購
  • 新產品上市
  • 其他的開發

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Charles River Laboratories
    • 企業概要
    • 產品介紹
    • 最近的開發情形
  • ICON plc
    • 公司概要
    • 產品介紹
    • 最近的開發情形
  • Paraxel International Corporation
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Quintiles IMS
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • SGS SA
    • 公司概要
    • 產品資訊
    • 最近的趨勢
  • 其他
    • 公司概要
    • 產品資訊
    • 最近的開發情形

第11章 COVID-19疫情造成的影響分析

  • COVID-19疫情對市場的影響分析
    • 對生產的直接的影響
    • 供應鏈與市場的混亂
    • 對企業及金融市場的財務性影響
  • COVID-19生產，進口，出口，各需求的影響分析
  • COVID-19疫情前後的市場轉變
  • 冠狀病毒(COVID-19)疫情對2020年市場規模的影響預測:情勢
  • COVID-19:市場相關微觀及宏觀要素的分析

在公司簡介中，財務細節和最近的發展基於可取得的現有信息，可能不包含非上市公司。

Product Code: VMR11210536

Value Market Research deeply researched the Global Clinical Trials Market to foresee a significant growth in the industry over the upcoming years. The global clinical trials market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global clinical trials market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this clinical trials market.

The next sections of the clinical trials market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Phase

Phase I

Phase II

Phase III

Phase IV

By Study Design

Interventional

Observational

Expanded Access

By Indication

Autoimmune/Inflammation

Pain Management

Oncology

CNS Condition

Diabetes

Obesity

Cardiovascular

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Clinical Trials Market
  • 2.2. Global Clinical Trials Market Snapshot

3 . CLINICAL TRIALS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Clinical Trials Market
  • 3.3. Market Restraints of Clinical Trials Market
  • 3.4. Opportunities of Clinical Trials Market
  • 3.5. Trends of Clinical Trials Market
  • 3.6. Porter's Five Force Analysis of Clinical Trials Market
  • 3.7. Clinical Trials Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Phase
    • 3.7.2 Market Attractive Analysis by Study Design
    • 3.7.3 Market Attractive Analysis by Indication
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Clinical Trials Value Chain Analysis
  • 4.2. Clinical Trials Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Clinical Trials Raw Material Manufactures List
    • 4.2.3. Price Trend of Clinical Trials Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY PHASE

  • 5.1 Overview by Phase
  • 5.2 Global Clinical Trials Market Analysis by Phase
  • 5.3 Market Analysis of Phase I by Regions
  • 5.4 Market Analysis of Phase II by Regions
  • 5.5 Market Analysis of Phase III by Regions
  • 5.6 Market Analysis of Phase IV by Regions

6 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN

  • 6.1 Overview by Study Design
  • 6.2 Global Clinical Trials Market Analysis by Study Design
  • 6.3 Market Analysis of Interventional by Regions
  • 6.4 Market Analysis of Observational by Regions
  • 6.5 Market Analysis of Expanded Access by Regions

7 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

  • 7.1 Overview by Indication
  • 7.2 Global Clinical Trials Market Analysis by Indication
  • 7.3 Market Analysis of Autoimmune/Inflammation by Regions
  • 7.4 Market Analysis of Pain Management by Regions
  • 7.5 Market Analysis of Oncology by Regions
  • 7.6 Market Analysis of CNS Condition by Regions
  • 7.7 Market Analysis of Diabetes by Regions
  • 7.8 Market Analysis of Obesity by Regions
  • 7.9 Market Analysis of Cardiovascular by Regions

8 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Clinical Trials Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Clinical Trials Market Estimate by Market Segment
    • 8.4.3. Europe Clinical Trials Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Clinical Trials Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Clinical Trials Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Clinical Trials Market Estimate by Market Segment
    • 8.6.3. Latin America Clinical Trials Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Clinical Trials Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Clinical Trials Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS COMPANIES

  • 9.1. Clinical Trials Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL TRIALS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Charles River Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. ICON plc
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Paraxel International Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Quintiles IMS
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. SGS SA
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Others
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 11.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 11.1.1. Direct Impact on Production
    • 11.1.2. Supply Chain and Market Disruption
    • 11.1.3. Financial Impact on Firms and Financial Markets
  • 11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 11.3. Pre V/S Post COVID-19 Market
  • 11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Clinical Trials Market Analysis by Phase (USD MN)
  • Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Study Design (USD MN)
  • Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Indication (USD MN)
  • Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
  • Global Clinical Trials Market by Geography (USD MN)
  • North America Clinical Trials Market Analysis by Phase (USD MN)
  • North America Clinical Trials Market Estimate by Study Design (USD MN)
  • North America Clinical Trials Market Estimate by Indication (USD MN)
  • North America Clinical Trials Market Estimate by Country (USD MN)
  • United State Clinical Trials Market Analysis by Phase (USD MN)
  • United State Clinical Trials Market Estimate by Study Design (USD MN)
  • United State Clinical Trials Market Analysis by Indication (USD MN)
  • Rest of North America Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of North America Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of North America Clinical Trials Market Estimate by Indication(USD MN)
  • Europe Clinical Trials Market Analysis by Phase (USD MN)
  • Europe Clinical Trials Market Estimate by Study Design (USD MN)
  • Europe Clinical Trials Market Estimate by Indication (USD MN)
  • United Kingdom Clinical Trials Market Analysis by Phase (USD MN)
  • United Kingdom Clinical Trials Market Estimate by Study Design (USD MN)
  • United Kingdom Clinical Trials Market Estimate by Indication (USD MN)
  • France Clinical Trials Market Analysis by Phase (USD MN)
  • France Clinical Trials Market Estimate by Study Design (USD MN)
  • France Clinical Trials Market Estimate by Indication (USD MN)
  • Germany Clinical Trials Market Analysis by Phase (USD MN)
  • Germany Clinical Trials Market Estimate by Study Design (USD MN)
  • Germany Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Europe Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Europe Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Europe Clinical Trials Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Country (USD MN)
  • China Clinical Trials Market Analysis by Phase (USD MN)
  • China Clinical Trials Market Estimate by Study Design (USD MN)
  • China Clinical Trials Market Estimate by Indication (USD MN)
  • Japan Clinical Trials Market Analysis by Phase (USD MN)
  • Japan Clinical Trials Market Estimate by Study Design (USD MN)
  • Japan Clinical Trials Market Estimate by Indication (USD MN)
  • India Clinical Trials Market Analysis by Phase (USD MN)
  • India Clinical Trials Market Estimate by Study Design (USD MN)
  • India Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials Market Analysis by Phase (USD MN)
  • Latin America Clinical Trials Market Estimate by Study Design (USD MN)
  • Latin America Clinical Trials Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials Market Estimate by Country (USD MN)
  • Brazil Clinical Trials Market Analysis by Phase (USD MN)
  • Brazil Clinical Trials Market Estimate by Study Design (USD MN)
  • Brazil Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Latin America Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Latin America Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Latin America Clinical Trials Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials Market Analysis by Phase (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Study Design (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Country (USD MN)
  • Middle East Clinical Trials Market Analysis by Phase (USD MN)
  • Middle East Clinical Trials Market Estimate by Study Design (USD MN)
  • Middle East Clinical Trials Market Estimate by Indication (USD MN)
  • Africa Clinical Trials Market Analysis by Phase (USD MN)
  • Africa Clinical Trials Market Estimate by Study Design (USD MN)
  • Africa Clinical Trials Market Estimate by Indication (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Clinical Trials Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trials Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Phase
  • Market Attractiveness Analysis by Study Design
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Clinical Trials Market Analysis by Phase (USD MN)
  • Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Study Design (USD MN)
  • Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Indication (USD MN)
  • Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
  • Latin America Clinical Trials Market by Revenue
  • Middle East & Africa Clinical Trials Market by Revenue
  • Recent Development in Clinical Trials Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.